Medicare Enrolled
Dr. Donald Gutman, M.D.
Internal Medicine · Folsom, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gutman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gutman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gutman
Dr. Donald Gutman is an internal medicine specialist in Folsom, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gutman performed 1,678 Medicare services across 1,003 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gutman received a total of $6,442 from 45 pharmaceutical and/or device companies across 391 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gutman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 19% volume in CA
$6,442 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,678
Medicare services
Top 19% in CA for internal medicine
1,003
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~88 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
622 | $59 | $188 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
233 | $86 | $265 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
174 | $1 | $3 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
109 | $135 | $269 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
101 | $32 | $100 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
98 | $76 | $143 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
80 | $61 | $152 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
37 | $11 | $30 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
31 | $49 | $160 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
29 | $109 | $271 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
27 | $66 | $169 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
26 | $23 | $99 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
25 | $231 | $578 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
22 | $172 | $343 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
20 | $83 | $246 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
16 | $39 | $151 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
15 | $171 | $428 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
13 | $46 | $118 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,442
Total received (2018-2024)
Avg $920/year across 7 years
Top 13% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
391
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,392 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$50 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$885
2023
$1,036
2022
$986
2021
$1,020
2020
$858
2019
$682
2018
$975
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$185
GlaxoSmithKline, LLC.
$129
Exact Sciences Corporation
$90
PFIZER INC.
$82
Sumitomo Pharma America, Inc.
$71
Janssen Pharmaceuticals, Inc
$66
Lilly USA, LLC
$52
ABBVIE INC.
$47
Amgen Inc.
$34
Regeneron Healthcare Solutions, Inc.
$30
Merck Sharp & Dohme LLC
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Otsuka America Pharmaceutical, Inc.
$18
Phathom Pharmaceuticals, Inc.
$18
SANOFI-AVENTIS U.S. LLC
$18
Top 3 companies account for 45.7% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$678
PFIZER INC.
$626
Boehringer Ingelheim Pharmaceuticals, Inc.
$606
ABBVIE INC.
$580
Novo Nordisk Inc
$470
Janssen Pharmaceuticals, Inc
$436
AstraZeneca Pharmaceuticals LP
$321
Takeda Pharmaceuticals U.S.A., Inc.
$268
Amarin Pharma Inc.
$177
Astellas Pharma US Inc
$162
Amgen Inc.
$161
AbbVie Inc.
$160
Allergan, Inc.
$143
Merck Sharp & Dohme Corporation
$140
Bayer HealthCare Pharmaceuticals Inc.
$135
Exact Sciences Corporation
$131
Kowa Pharmaceuticals America, Inc.
$121
Lilly USA, LLC
$109
GENZYME CORPORATION
$108
Sumitomo Pharma America, Inc.
$97
SANOFI-AVENTIS U.S. LLC
$68
Bausch Health US, LLC
$66
Regeneron Healthcare Solutions, Inc.
$65
Novartis Pharmaceuticals Corporation
$62
Collegium Pharmaceutical, Inc.
$53
Radius Health, Inc.
$50
Sunovion Pharmaceuticals Inc.
$49
Biohaven Pharmaceuticals, Inc.
$42
Dexcom, Inc.
$36
Otsuka America Pharmaceutical, Inc.
$32
E.R. Squibb & Sons, L.L.C.
$32
Scilex Pharmaceuticals Inc.
$30
Eisai Inc.
$29
Merck Sharp & Dohme LLC
$26
Bardy Diagnostics, Inc.
$21
Avanir Pharmaceuticals, Inc.
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Phathom Pharmaceuticals, Inc.
$18
Mannkind Corporation
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
IDORSIA PHARMACEUTICALS US INC
$14
Boston Scientific Corporation
$13
Egalet US Inc
$13
Acerus Pharmaceuticals Corporation
$13
Abbott Laboratories
$13
Top 3 companies account for 29.7% of all-time payments
Associated products mentioned in payments ›
ADVAIR · AFREZZA · AIRSUPRA · ANORO · APLENZIN · AREXVY · BAQSIMI · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · CHANTIX · COMIRNATY · CREON · Carnation Ambulatory Monitor · Cologuard Collection Kit · DIFICID · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · GEMTESA · GENERAL PAIN MANAGEMENT · INVOKANA · JANUVIA · JARDIANCE · JEVTANA · KAPSPARGO · Kerendia · LEQVIO · LIBTAYO · LINZESS · LONHALA MAGNAIR · LYBREL · LYRICA · Livalo · MYRBETRIQ · Myrbetriq · NUEDEXTA · NURTEC ODT · Natesto · Nuedexta · OFEV · Otezla · Ozempic · PNEUMOVAX 23 · PRADAXA · PREMARIN · PREVNAR - 13 · Prolia · QULIPTA · QUVIVIQ · Rybelsus · SEGLENTIS · SHINGRIX · SPIRIVA RESPIMAT · SPRAVATO · SPRIX · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TZIELD · Tresiba · Trintellix · Tymlos · UBRELVY · Utibron · VESICARE · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · WELLBUTRIN · XARELTO · XIFAXAN · XTAMPZA · ZEPBOUND · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
1,172
Per 100K population
74.0
County median income
$88,724
Nearest hospital
MERCY HOSPITAL OF FOLSOM
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gutman is a clinical cardiology specialist, with above-average Medicare volume (top 19% in CA), with low-engagement industry engagement in the top 13% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gutman experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Gutman performed 622 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gutman receive payments from pharmaceutical companies?
Yes. Dr. Gutman received a total of $6,442 from 45 companies across 391 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gutman's costs compare to other internal medicine physicians in Folsom?
Dr. Gutman's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gutman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Folsom
Browse internal medicine physicians in Folsom ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology